Rethinking Off-Label Regulation in the Wake of Sorrell v. IMS Health: Can State Involvement Compensate for Waning FDA Authority to Curb Commercial Free Speech?

Zborowsky, Ashley A.

2012

View/Download File

ahc_content_396752.pdf (199.27 KB)

Persistent link to this item

https://hdl.handle.net/11299/155954

Statistics

View Statistics

Title

Rethinking Off-Label Regulation in the Wake of Sorrell v. IMS Health: Can State Involvement Compensate for Waning FDA Authority to Curb Commercial Free Speech?

Authors

Zborowsky, Ashley A.

Published Date

2012

Publisher

University of Minnesota. Consortium on Law and Values in Health, Environment & the Life Sciences

Type

Article

Collections

Volume 13, Issue 2 (Spring 2012)

Previously Published Citation

Minnesota Journal of Law, Science & Technology, Volume 13, Issue 2 (Spring 2012), pages 925-949

Suggested citation

Zborowsky, Ashley A.. (2012). Rethinking Off-Label Regulation in the Wake of Sorrell v. IMS Health: Can State Involvement Compensate for Waning FDA Authority to Curb Commercial Free Speech?. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/155954.

Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.